UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary

Q: What sector and industry does UroGen Pharma (URGN) operate in?

UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 348.937K
Day Range	- - -
52 Wk Range	8.690 - 24.130
Market Cap	$468.608M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	15.08%
Days to Cover	21.38

Recent News

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Avi Kapoor

Two Months After Hamas Attacks, Gaza Conflict Intensifies As Ceasefire Efforts Falter

Two months after Hamas attacks, US President Biden, UNSC & King of Jordan call for ceasefire. Israeli stocks rise, US envoy to UN against ceasefire. Investigations into civilian casualties & use of phosphorus munitions. UNSC to convene tomorrow.

Piero Cingari

Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch

Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy UroGen Pharma (URGN) stock?

You can purchase shares of UroGen Pharma (NASDAQ:URGN) through any online brokerage.

View our list of the best stock brokerages

Who are UroGen Pharma (URGN) competitors?

There are no as such competitors for UroGen Pharma.

What is the target price for UroGen Pharma (URGN) stock?

There is no analysis for UroGen Pharma

Current Stock Price for UroGen Pharma (URGN)?

The stock price for UroGen Pharma (NASDAQ: URGN) is $12.97 last updated June 12, 2024 at 6:48 PM EDT.

Does UroGen Pharma (URGN) pay a dividend

There are no upcoming dividends for UroGen Pharma.

When is UroGen Pharma (NASDAQ:URGN) reporting earnings?

UroGen Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is UroGen Pharma (URGN) going to split?

There is no upcoming split for UroGen Pharma.

What sector and industry does UroGen Pharma (URGN) operate in?

UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.